Brightlands Venture Partners

Matisse Pharmaceuticals B.V. is a biotechnology company based in Geleen, the Netherlands, specializing in the development of pharmaceutical therapies aimed at treating sepsis and related disorders associated with fulminant inflammation. Founded in 2014, the company is focused on creating innovative treatments to neutralize cytotoxic components of the inflammatory system. Its lead product, M6229, is currently in the pre-clinical phase and targets severe sepsis and septic shock, aiming to provide healthcare professionals with advanced therapeutic options to improve patient outcomes in critical conditions.

Black Bear Carbon BV specializes in the conversion of waste tires into carbon black and green energy, operating from its base in Nederweert, the Netherlands, since its founding in 2010. The company utilizes a circular economy model, transforming end-of-life tires into sustainable products that serve various industries. Its carbon black, derived from controlled pyrolysis and partial combustion of hydrocarbons, is utilized in applications such as tires, technical rubber products, plastics, paints, and inks. In addition to producing carbon black, Black Bear Carbon generates electricity from its operations, which powers its tire shredding processes and supplies energy to local industries and grids. Through these efforts, the company provides businesses with recyclable carbon compounds, contributing to reduced reliance on oil and lower carbon dioxide emissions.

AvL Motion develops autonomous harvesting machines for selective harvesting in agriculture, focusing on asparagus and other crops. The company builds a selective asparagus harvester and related robotics that enable moving and harvesting white asparagus, with applicability to green asparagus and zucchini. Its solutions bring industrial automation to the agricultural sector and the food industry, allowing labor reduction and process optimization for small and medium-sized enterprises. Headquartered in Overloon, the Netherlands, AvL Motion's technology supports labor-intensive harvesting tasks by offering autonomous harvesting applications for horticulture.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.